Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

28 ArticlesUSFDA

2 / 3

Cadila Recalls Microbial Contaminated API Used To Prevent Nausea, Vomiting Caused By Chemotherapy

Cadila Pharmaceuticals – an industry leader in synthesizing APIs has initiated a recall of Ondansetron HCI API supplied to LLC LENS Phanna in Russia, ...

Amerisource Health Services Recalls 40 Lakh Antidepressant Tablets Manufactured By Cadila Healthcare

Based out of largest city in the US Columbus, Ohio – Amerisource Health Services (a subsidiary of AmerisourceBergen Corporation) – offers unit ...

Jubilant HollisterStier Recalls Misbranded Allergenic Extract

Jubilant HollisterStier based Spokane, Washington, USA offering sterile manufacturing services through Commercial liquid and lyophilized products in vials and ...

Sun Pharma Acquires Ocular Technologies and Launches Authorized Generic (AG) Versions of 4 Tablets

Sun Pharma – the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company providing medicines to ...

Lupin Goa Recalls 26,463 Bottles of Lisinopril Tablets and 3,192 Bottles Escitalopram Tablets

Drug major Lupin has initiated a recall of Escitalopram Tablets manufactured at its Goa facility (ANDA approcal received in September, 2012) which is a generic ...

Sun Pharma Recalls 12,109 Bottles of Tablets Used To Treat Heart Failure

Drug major Sun Pharmaceutical Industries Inc. (the US subsidiary of Sun Pharma), initiated a nationwide recall of its Carvedilol Tablets used in the treatment ...

Lupin Goa Recalls 55,348 Bottles of Tablets Used For The Treatment of High Blood Pressure & Chest Pain

Drug major Lupin Limited has initiated a recall of 55,348 bottles of Amlodipine Besylate Tablets. This recall has been initiated for the manufacturing ...

Cadila Healthcare Recalls 14,808 Bottles of Capsules Used in The Treatment of Parkinson’s Disease

Cadila Healthcare – the 4th largest player in the Indian pharma market with 16 of the group’s brands feature amongst the top 300 pharma brands in India as ...

Cadila Healthcare Recalls 2.2 Lakh Bottles of Venlafaxine Capsule

Cadila Healthcare – the 4th largest player in the Indian pharma market with 16 of the group’s brands feature amongst the top 300 pharma brands in ...

Sun Pharma – Almirall Enter Into Agreement for Tildrakizumab Inhibitor for Treatment Against Psoriasis

Sun Pharmaceutical Industries and Almirall – the spanish giant announced a licensing agreement on the development and commercialization of tildrakizumab ...